SERUM (SRM) Project Overview and Core Mechanisms

SERUM (SRM) was once an ambitious decentralized exchange (DEX) protocol on the Solana blockchain, with the core goal of combining the speed and low-cost advantages of centralized exchanges while maintaining decentralization. The Serum protocol operated via an on-chain order book model, supported cross-chain transactions, and was compatible with Ethereum ERC20 tokens. The SRM token was the native utility and governance token of the Serum ecosystem, granting holders trading fee discounts and participation in platform governance votes. Additionally, SRM rewarded node operators through a staking mechanism and implemented a "buy-and-burn" strategy to reduce token supply.

SERUM (SRM) Token Status Analysis: What are its value and investment prospects after FTX's bankruptcy?

Devastating Impact of FTX Bankruptcy on SERUM

The SERUM project was jointly initiated by FTX, Alameda Research, and the Solana Foundation. However, FTX's bankruptcy in November 2022 dealt a devastating blow to Serum. As FTX insiders held upgrade permissions for the Serum code, FTX's collapse directly led to the "failure" of the Serum mainnet program, severely threatening its security and bringing project development to a standstill. FTX's balance sheet previously showed it held a large amount of SRM tokens, but the value of these assets significantly depreciated after the bankruptcy.

SERUM (SRM) Token Status Analysis: What are its value and investment prospects after FTX's bankruptcy?

Community Fork and the Rise of OpenBook

Facing the stagnation and security risks of the original Serum protocol, the Solana developer community quickly took action to hard fork the Serum protocol and create a new decentralized exchange protocol, OpenBook. Since then, major DeFi protocols in the Solana ecosystem, such as Jupiter and Raydium, have switched to using OpenBook, making OpenBook the de facto successor to Serum's core functions. As of September 2026, OpenBook's daily trading volume has exceeded $1 million, while the trading volume and liquidity of the original Serum protocol have dropped to near zero.

SERUM (SRM) Token Status Analysis: What are its value and investment prospects after FTX's bankruptcy?

SRM Token Market Status and Risks

As of September 26, 2026, the price of the SRM token fluctuated between $0.0065 and $0.0073, with a 24-hour trading volume of only approximately $23,600 to $28,710, and a market capitalization of about $1.72 million to $3.64 million. SRM's all-time high was $13.78 (September 11, 2021), while its all-time low was $0.0001671. Currently, the circulating supply of SRM is approximately 263 million to 373 million tokens, with a maximum supply of 10 billion tokens.

SERUM (SRM) Token Status Analysis: What are its value and investment prospects after FTX's bankruptcy?

Given that the Serum project has lost its core role in the Solana ecosystem after the FTX bankruptcy and lacks active development and maintenance, the SRM token has been regarded by many analysts as a speculative legacy asset rather than an active DeFi protocol token. Its value fluctuations no longer depend on user growth or ecosystem development but are highly uncertain. The lack of active development, the removal of major trading pairs, and the huge disparity between total supply and circulating supply are all major risks facing SRM. Currently, the token has no active trading market, and liquidity is extremely depleted.

Is SERUM (SRM) Worth Long-Term Investment?

SERUM (SRM) Token Status Analysis: What are its value and investment prospects after FTX's bankruptcy?

Overall, the long-term investment prospects for SERUM (SRM) tokens are extremely unclear. Since its core protocol has stalled due to the FTX bankruptcy, and the community has effectively migrated and replaced it through OpenBook, the original SRM token has lost its utility and growth potential as the native token of an active DeFi protocol. The current extremely low trading volume and liquidity further confirm its declining market position. For investors seeking long-term value investments, the structural risks and uncertainties currently facing SRM tokens are extremely high, and it is not recommended to consider it a promising investment asset.